Literature DB >> 12162334

The Ca/P range of nanoapatitic calcium phosphate cements.

F C M Driessens1, M G Boltong, E A P de Maeyer, R Wenz, B Nies, J A Planell.   

Abstract

Nanoapatites are apatites consisting of nanometer size crystals. The commercial calcium phosphate cements set by the precipitation of nanoapatitic calcium phosphates in the range 1.5 < or = Ca/P < 1.8. In this study it is shown that a continuum of nanoapatites can precipitate in the range 0.8 < Ca/P< or = 1.5. In order to be formed these nanoapatites need to incorporate K+ ions. In addition they can incorporate some Na+ ions. Upon immersion in aqueous solutions these nanoapatites loose phosphate, K+ and Na+ so that in an open system they are transformed into calcium deficient hydroxyapatite Ca9(HPO4)(PO4)5OH within about 2 months.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12162334     DOI: 10.1016/s0142-9612(02)00151-5

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  4 in total

1.  Injectable and fast resorbable calcium phosphate cement for body-setting bone grafts.

Authors:  I Rajzer; O Castaño; E Engel; J A Planell
Journal:  J Mater Sci Mater Med       Date:  2010-04-13       Impact factor: 3.896

2.  Alkali ion substituted calcium phosphate cement formation from mechanically activated reactants.

Authors:  U Gbureck; R Thull; J E Barralet
Journal:  J Mater Sci Mater Med       Date:  2005-05       Impact factor: 3.896

Review 3.  Biomaterials in orthopaedics.

Authors:  M Navarro; A Michiardi; O Castaño; J A Planell
Journal:  J R Soc Interface       Date:  2008-10-06       Impact factor: 4.118

4.  3D biodegradable scaffolds of polycaprolactone with silicate-containing hydroxyapatite microparticles for bone tissue engineering: high-resolution tomography and in vitro study.

Authors:  Svetlana Shkarina; Roman Shkarin; Venera Weinhardt; Elizaveta Melnik; Gabriele Vacun; Petra J Kluger; Kateryna Loza; Matthias Epple; Sergei I Ivlev; Tilo Baumbach; Maria A Surmeneva; Roman A Surmenev
Journal:  Sci Rep       Date:  2018-06-11       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.